Definitive Contract 75F40122C00132
Award Date
8/31/22
Potential Completion Date
8/31/27
Potential Value
$229K
Federal Agency
Food and Drug Administration
Ultimate Awardee
State Of Delaware
NAICS Category
923120 - Administration of Public Health Programs
PSC Category
H265 - Equipment And Materials Testing- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Leipsic, DE 19901, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Food and Drug Administration (FDA), a civilian agency, to the Executive Office of the Governor of Delaware's Division of Public Health. The contract, valued at $22,674.88, is a definitive, firm-fixed price contract and does not have a set-aside designation. The contract supports the Division of Public Health in conducting inspections of certified mammography facilities in the state to ensure compliance with FDA quality standards. The Division of Public...
This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
The Food and Drug Administration (FDA) awarded a $483,881.81 firm-fixed-price definitive contract to the Arkansas Department of Health (ADH) for the "ARKANSAS MQSA INSPECTION CONTRACT". This contract supports inspections of certified non-federal mammography facilities in Arkansas to ensure compliance with the Mammography Quality Standards Act (MQSA). ADH was selected as the sole source provider for this requirement due to its legal authority under state law to access commercial...
The U.S. Food and Drug Administration (FDA) awarded a $262,548.81 firm fixed-price contract to the South Dakota Department of Health (SD DOH) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This contract, awarded on June 30, 2022, has an ultimate completion date of January 1, 2028. The contract was issued as a sole-source award, as the state government organization is the...
This is a $501,949.66 firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Rhode Island Department of Health to conduct inspections of mammography facilities in Rhode Island under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of January 14, 2028. The Rhode Island Department of Health, a U.S. state government entity, will be the prime contractor delivering these inspection services. This contract award is not associated...
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...
This is a $2,685,565.01 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH) for Massachusetts MQSA (Mammography Quality Standards Act) new contract services. The contract has no set-aside designation and an ultimate completion date of January 21, 2028. MDPH, a U.S. state government agency, is the prime contractor and will provide specialized public health services to the FDA, including food and tobacco...
The Food and Drug Administration awarded a firm fixed price definitive contract valued at one million one hundred thirty thousand fifteen dollars and eighty-one cents ($1,130,015.81) to the Florida Department of Health for MQSA inspections. The place of performance is Tallahassee, Florida. No set-aside designation was used for this contract. As the designated state health agency for Florida, the Department of Health will utilize its resources across the state to conduct Mammography Quality...
This $370,617 firm fixed price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration on September 25, 2020 to Computer Evidence Specialists, LLC (doing business as C E S) for REGION (1) DELAWARE DIRECTED UNDERCOVER BUY INSPECTIONS. No set-aside designation was used. Performance will take place in Westlake, Maryland, with a completion date of September 29, 2022. The FDA utilizes directed undercover buy inspections to monitor compliance with laws...
This firm-fixed-price contract was awarded by the Food and Drug Administration (FDA) to the Colorado Department of Public Health & Environment (CDPHE), a state government entity, to provide Mammography Quality Standards Act (MQSA) inspections. The contract has a ceiling value of $453,010.00 and a period of performance from March 1, 2003, to February 28, 2006. CDPHE, a subsidiary of the City of Lakewood, has a long history of executing federal contracts and grants across various public health...